Industries > Pharma > Biological Safety Testing Market Report 2019-2029

Biological Safety Testing Market Report 2019-2029

By Product, by Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), by Test, by Region and Segment Reports

PAGES: 172
PRODUCT CODE: PHA0509
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0509 Categories: , Tag:

Biological safety tests refer to the test procedures that are performed to ensure non-contamination of biopharmaceuticals and vaccines and also to comply with relevant regulations. These include various types of sterility tests, authentication and cell line characterization tests, biological charge tests, endotoxin tests, adventitious agent detection tests, residual host contamination detection test, etc.

Market Overview and Trends
Biotechnology-derived products or biological products have made their way effectively into various aspects of health care, including the diagnosis, prevention and treatment of diseases. However, there remain potential safety problems that generally derive from their manufacturing processes and also from the complex biological and structural characteristics of these products. Therefore, these products require detailed and systematic biological safety tests that ultimately allow an adequate safety assessment before any type of clinical investigation. Therefore, the market should see significant growth worldwide during the forecast period.

Factors Influencing the Market Growth:
• Increase use of biologics, which require highly efficient biological safety testing tools
• Rise in disease burden through lifestyle-associated chronic diseases such as cancer and diabetes
• Incremental R&D investments by major companies and research communities
• Laboratory-based contaminations which necessitates the usage of biological safety testing tool

Factors Restraining the Market Growth:
• Concerns regarding contamination of tissues, challenges in maintaining sterility of cell lines and chances of cross-contamination
• Stringent governmental regulations

Market Segmentation 2019-2029:
The Biological Safety Testing market is segmented by Product, By Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), By Test, By Region, And Segment Forecasts

Market Segmentation Covered:
• Global Biological Safety Testing Products Market 2019-2029
– Global Reagents & kits Market 2019-2029
– Global Instruments Market 2019-2029
– Global Services Market 2019-2029
• Global Biological Safety Testing by Application Market 2019-2029
– Global Stem Cell Market 2019-2029
– Global Tissue & tissue-based products Market 2019-2029
– Global Gene therapy Market 2019-2029
– Global Blood & blood-based therapy Market 2019-2029
– Global Vaccines & therapeutics Market 2019-2029
– Global Biological Safety Test Market 2019-2029
• Global Sterility tests Market 2019-2029
– Global Cell line authentication and characterization tests Market 2019-2029
– Global Bioburden tests Market 2019-2029
– Global Endotoxin tests Market 2019-2029
– Global Adventitious agent detection tests Market 2019-2029
– Global Residual host contamination detection tests Market 2019-2029
– Global Others Market 2019-2029
Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Biological Safety Testing market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Charles River Laboratories, Lonza Group, Merck Millipore, Wuxi PharmaTech, Avance Biosciences, Cytovance Biologics, Promega Corporation, Thermo Fisher Scientific, Toxikon and Eurofins Scientific
Key questions answered by this report:
• What is the current size of the total global Biological Safety Testing market?
• How much will this market be worth from 2018 to 2029?
• How is the Biological Safety Testing market evolving?
• What is driving and restraining the Biological Safety Testing market?
• What are the market shares of each segment of the overall Biological Safety Testing market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each Biological Safety Testing market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each Biological Safety Testing market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for Biological Safety Testing market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the Biological Safety Testing market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Biological Safety Testing market. You find data, trends and predictions.

Buy our report today Biological Safety Testing Market 2019-2029: By Product, By Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), By Test, By Region, And Segment Forecasts

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biological Safety Testing Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Biological Safety Testing Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category